Ontology highlight
ABSTRACT:
SUBMITTER: Chang YW
PROVIDER: S-EPMC7664121 | biostudies-literature | 2020 Nov
REPOSITORIES: biostudies-literature
Chang Yi-Wen YW Hsu Chia-Lang CL Tang Cheng-Wei CW Chen Xiang-Jun XJ Huang Hsuan-Cheng HC Juan Hsueh-Fen HF
Molecular & cellular proteomics : MCP 20200811 11
The EGFR tyrosine kinase inhibitor gefitinib is commonly used for lung cancer patients. However, some patients eventually become resistant to gefitinib and develop progressive disease. Here, we indicate that ecto-ATP synthase, which ectopically translocated from mitochondrial inner membrane to plasma membrane, is considered as a potential therapeutic target for drug-resistant cells. Quantitative multi-omics profiling reveals that ecto-ATP synthase inhibitor mediates CK2-dependent phosphorylation ...[more]